Primary graft dysfunction
- PMID: 19131529
- DOI: 10.1513/pats.200808-082GO
Primary graft dysfunction
Abstract
Primary graft dysfunction (PGD) is a severe form of ischemia/reperfusion acute lung injury that is a major cause of early morbidity and mortality after lung transplantation. Survivors of PGD have worse long-term lung function and an increased chance of developing bronchiolitis obliterans syndrome (BOS), the manifestation of chronic rejection. This review examines the current state of PGD research in the context of a recent consensus statement by the International Society for Heart and Lung Transplantation (ISHLT) designed to standardize the definition of PGD in clinical research efforts. This article will review this definition and issues surrounding it, outcome studies examining the long-term effects of PGD, and the established clinical risk factors for PGD. Translational studies exploring the pathogenesis of PGD will be highlighted, and the current state of PGD prevention and management will also be described. Finally, we will summarize efforts at finding genetic and molecular markers for PGD and discuss future directions for PGD research.
Similar articles
-
Primary graft dysfunction and long-term pulmonary function after lung transplantation.J Heart Lung Transplant. 2007 Oct;26(10):1004-11. doi: 10.1016/j.healun.2007.07.018. J Heart Lung Transplant. 2007. PMID: 17919620
-
Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.Semin Respir Crit Care Med. 2010 Apr;31(2):161-71. doi: 10.1055/s-0030-1249111. Epub 2010 Mar 30. Semin Respir Crit Care Med. 2010. PMID: 20354929 Review.
-
Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.J Heart Lung Transplant. 2006 Apr;25(4):371-8. doi: 10.1016/j.healun.2005.11.436. Epub 2006 Feb 28. J Heart Lung Transplant. 2006. PMID: 16563963
-
Outcome of lung transplanted patients with primary graft dysfunction.Eur J Cardiothorac Surg. 2007 Jan;31(1):75-82. doi: 10.1016/j.ejcts.2006.10.024. Epub 2006 Nov 28. Eur J Cardiothorac Surg. 2007. PMID: 17134909
-
Primary Graft Dysfunction (PGD) Following Lung Transplantation.Semin Respir Crit Care Med. 2018 Apr;39(2):148-154. doi: 10.1055/s-0037-1615797. Epub 2018 Mar 28. Semin Respir Crit Care Med. 2018. PMID: 29590671 Review.
Cited by
-
Autoantibodies in lung transplantation.Transpl Int. 2020 Jan;33(1):41-49. doi: 10.1111/tri.13487. Epub 2019 Aug 27. Transpl Int. 2020. PMID: 31393646 Free PMC article. Review.
-
IL-17A mediates early post-transplant lesions after heterotopic trachea allotransplantation in Mice.PLoS One. 2013 Jul 30;8(7):e70236. doi: 10.1371/journal.pone.0070236. Print 2013. PLoS One. 2013. PMID: 23936171 Free PMC article.
-
Nitrite attenuates mitochondrial impairment and vascular permeability induced by ischemia-reperfusion injury in the lung.Am J Physiol Lung Cell Mol Physiol. 2020 Apr 1;318(4):L580-L591. doi: 10.1152/ajplung.00367.2018. Epub 2020 Feb 19. Am J Physiol Lung Cell Mol Physiol. 2020. PMID: 32073901 Free PMC article.
-
Lymphatic Vessels: The Next Frontier in Lung Transplant.Ann Am Thorac Soc. 2017 Sep;14(Supplement_3):S226-S232. doi: 10.1513/AnnalsATS.201606-465MG. Ann Am Thorac Soc. 2017. PMID: 28945468 Free PMC article. Review.
-
Lung transplantation for cystic fibrosis.Proc Am Thorac Soc. 2009 Dec;6(8):619-33. doi: 10.1513/pats.2009008-088TL. Proc Am Thorac Soc. 2009. PMID: 20008865 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous